Drug
Fluticasone Furoate And Vilanterol Inhalation
Fluticasone Furoate And Vilanterol Inhalation: highest development phase Phase 3, developed by Sandoz. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fluticasone furoate and vilanterol inhalation powder NCT07223294 | Phase 3 | Respiratory |
Latest
No recent events.
Follow Fluticasone Furoate And Vilanterol Inhalation on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.